We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.84T Turnover 17.26%
1-Year Est. Return 33.86%
 

JPMorgan Chase is a banking group formed in 2000 when two New York banks, J.P. Morgan & Co. and Chase Manhattan, merged. Its oldest predecessor, the Bank of the Manhattan Company, dates to 1799, and J.P. Morgan & Co. was started in 1871 by the financier J. P. Morgan. Bank One was folded in later, and the group took over assets of Bear Stearns, Washington Mutual and First Republic. It offers investment banking and, under the Chase brand, retail banking and credit cards. Its work is organized into three businesses: consumer and community banking under the Chase name, asset and wealth management under the J.P. Morgan name, and commercial and investment banking. Together the J.P. Morgan and Chase brands serve consumers, small businesses, and corporate, institutional and government clients.

This Fund
S&P 500
This Quarter Est. Return
+3.7%
1 Year Est. Return
+33.86%
3 Year Est. Return
+136.24%
5 Year Est. Return
+161.78%
10 Year Est. Return
+586.53%
AUM
$1.84T
AUM Growth
+$35.8B
Cap. Flow
-$4.48B
Cap. Flow %
-0.24%
Top 10 Hldgs %
27.89%
Holding
8,712
New
1,003
Increased
3,695
Reduced
2,628
Closed
501
Avg Time Held Equity + Options
5.2 years
Top 10 Avg Time Held Equity + Options
6.1 years
Top 20 Avg Time Held Equity + Options
4.5 years
Avg Time Held Equity only
5.5 years
Top 10 Avg Time Held Equity only
6.2 years
Top 20 Avg Time Held Equity only
5.1 years

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$10.5B
2
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$3.37B
3
NFLX icon
Netflix
NFLX
+$3.2B
4
AMZN icon
Amazon
AMZN
+$2.91B
5
NVDA icon
NVIDIA
NVDA
+$2.74B

Sector Composition

Rank Sector Weight
1 Technology 29.8%
2 Miscellaneous 24.37%
3 Communication Services 7.79%
4 Financials 7.78%
5 Healthcare 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DCOR icon
4101
Dimensional US Core Equity 1 ETF
DCOR
$3.49B
$2.05M ﹤0.01%
24,649
+6,701
+37% +$560K
2023 Q4
11 quarters
AS icon
4102
PUT
Amer Sports
AS
$16.9B
$2.04M ﹤0.01%
+75,000
New +$2.4M
2026 Q3
0 quarters
WLKP icon
4103
Westlake Chemical Partners
WLKP
$747M
$2.04M ﹤0.01%
95,305
– –
2021 Q3
20 quarters
OUNZ icon
4104
VanEck Merk Gold ETF
OUNZ
$2.48B
$2.04M ﹤0.01%
50,811
+13,687
+37% +$561K
2024 Q4
7 quarters
VG icon
4105
PUT
Venture Global
VG
$31.4B
$2.04M ﹤0.01%
+162,500
New +$2.22M
2026 Q3
0 quarters
BLKB icon
4106
Blackbaud
BLKB
$2.43B
$2.04M ﹤0.01%
47,151
+11,605
+33% +$476K
2014 Q4
47 quarters
APXT icon
4107
Apex Treasury
APXT
$469M
$2.03M ﹤0.01%
199,950
+184,288
+1,177% +$1.86M
2026 Q2
1 quarter
IONS icon
4108
PUT
Ionis Pharmaceuticals
IONS
$4.66B
$2.02M ﹤0.01%
44,100
-120,900
-73% -$6.87M
2026 Q1
2 quarters
ATI icon
4109
CALL
ATI
ATI
$23.5B
$2.02M ﹤0.01%
+10,700
New +$2.14M
2026 Q3
0 quarters
ASTH icon
4110
Astrana Health
ASTH
$1.58B
$2.02M ﹤0.01%
54,830
+5,208
+10% +$205K
2018 Q2
33 quarters
CHWY icon
4111
PUT
Chewy
CHWY
$8.69B
$2.02M ﹤0.01%
+110,600
New +$2.41M
2026 Q3
0 quarters
AB icon
4112
AllianceBernstein
AB
$3.08B
$2.01M ﹤0.01%
56,743
-3,683
-6% -$135K
2013 Q2
53 quarters
PHAT icon
4113
Phathom Pharmaceuticals
PHAT
$478M
$2.01M ﹤0.01%
273,767
-1,484
-0.5% -$14K
2019 Q4
27 quarters
PSDM icon
4114
PGIM Short Duration Multi-Sector Bond ETF
PSDM
$282M
$2.01M ﹤0.01%
40,133
+1,576
+4% +$80K
2026 Q1
2 quarters
VZLA icon
4115
Vizsla Silver
VZLA
$1.04B
$2.01M ﹤0.01%
523,421
+482,877
+1,191% +$1.76M
2024 Q3
8 quarters
ASIC icon
4116
Ategrity Specialty Insurance
ASIC
$1.17B
$2.01M ﹤0.01%
76,218
-2,902
-4% -$73.9K
2025 Q3
4 quarters
RXRX icon
4117
Recursion Pharmaceuticals
RXRX
$1.81B
$2.01M ﹤0.01%
469,848
-676,668
-59% -$2.29M
2021 Q2
21 quarters
AVPT icon
4118
AvePoint
AVPT
$3.45B
$2M ﹤0.01%
139,260
-240,337
-63% -$3.14M
2021 Q3
20 quarters
PBYI icon
4119
Puma Biotechnology
PBYI
$402M
$2M ﹤0.01%
204,395
-6,944
-3% -$61.1K
2013 Q2
53 quarters
LIT icon
4120
Global X Lithium & Battery Tech ETF
LIT
$1.03B
$1.99M ﹤0.01%
29,065
-25,973
-47% -$1.87M
2019 Q4
27 quarters
TEVA icon
4121
PUT
Teva Pharmaceutical Industries
TEVA
$49.7B
$1.99M ﹤0.01%
50,000
– –
2025 Q3
4 quarters
PFFD icon
4122
Global X US Preferred ETF
PFFD
$1.81B
$1.99M ﹤0.01%
112,716
+3,005
+3% +$55.2K
2023 Q3
12 quarters
GDE icon
4123
WisdomTree Efficient Gold Plus Equity Strategy Fund
GDE
$364M
$1.98M ﹤0.01%
30,920
+5,483
+22% +$357K
2025 Q3
4 quarters
RCKT icon
4124
Rocket Pharmaceuticals
RCKT
$257M
$1.98M ﹤0.01%
763,415
-1,224,998
-62% -$4.25M
2018 Q2
33 quarters
JENA icon
4125
Jena Acquisition Corp II
JENA
$303M
$1.97M ﹤0.01%
190,000
+50,000
+36% +$521K
2025 Q3
4 quarters

Similar funds

JP Morgan Chase's Q3 2026 Portfolio in Review

As of Q3 2026, JP Morgan Chase held 8,712 positions worth $1.84T, up 2% from $1.81T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

JP Morgan Chase's Q3 2026 filing shows 1,003 new, 3,695 increased, 2,628 reduced and 501 closed positions. Its largest new stake was JPMorgan Preferred and Income Securities ETF: 21,414,812 shares worth $1.04B. The largest sale was iShares Core S&P 500 ETF, an estimated $6.13B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Communication Services.

  • JP Morgan Chase's largest Q3 2026 buy was JPMorgan Preferred and Income Securities ETF: 21,414,812 shares worth $1.04B.
  • JP Morgan Chase added most to Microsoft in Q3 2026, an estimated $10.5B increase.
  • JP Morgan Chase's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $6.13B.
  • JP Morgan Chase fully exited AvalonBay Communities in Q3 2026, selling an estimated $882M.
  • JP Morgan Chase's ten largest holdings make up 28% of its $1.84T portfolio in Q3 2026.
  • JP Morgan Chase opened 1,003 new positions and closed 501 in Q3 2026.
  • JP Morgan Chase's portfolio value rose 2% quarter-over-quarter to $1.84T.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.